| Total income and fair value gain/(loss) on financial instruments |
18,235 |
2,149 |
(313) |
2,843 |
9,493 |
| Income less expenses before reversal/(impairment losses) and provision |
(13,873) |
(24,880) |
(38,114) |
(33,971) |
(27,403) |
| Reversal of impairment |
-- |
6,126 |
-- |
-- |
-- |
| Impairment losses |
-- |
(5,700) |
(26,000) |
-- |
(1,875) |
| Operating loss after reversal/(impairment losses) and provision |
(13,873) |
(24,454) |
(64,114) |
(33,971) |
(29,278) |
| Finance cost |
(1,218) |
(1,706) |
(620) |
-- |
-- |
| Gain on disposal of an associate |
-- |
-- |
-- |
209 |
-- |
| Share of results of associates |
-- |
-- |
-- |
-- |
(1,067) |
| Loss before taxation |
(15,091) |
(26,160) |
(64,734) |
(33,762) |
(30,345) |
| Tax credit/(Taxation) |
2,493 |
1,764 |
(1,265) |
2,669 |
2,982 |
| Loss for the year |
(12,598) |
(24,396) |
(65,999) |
(31,093) |
(27,363) |
| Non-controlling interests |
-- |
1 |
(49) |
6 |
4 |
| Loss attributable to shareholders of the Company |
(12,598) |
(24,395) |
(66,048) |
(31,087) |
(27,359) |
English Version
